| Entry |
|
| Name |
BCL2-overexpression to intrinsic apoptotic pathway
|
| Definition |
BCL2* -| BAX -> CYCS == APAF1 -> CASP9 -> (CASP3,CASP7) |
| Expanded |
596v1 -| 581 -> 54205 == 317 -> 842 -> (836,840) |
| Class |
|
| Type |
Variant
|
| Pathway |
|
| Disease |
|
| Gene |
| 596 | BCL2; BCL2, apoptosis regulator |
| 581 | BAX; BCL2 associated X, apoptosis regulator |
| 54205 | CYCS; cytochrome c, somatic |
| 317 | APAF1; apoptotic peptidase activating factor 1 |
|
| Variant |
596v1 (BCL2*) BCL2 overepression
|
| Reference |
|
| Authors |
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. |
| Title |
Apoptosis and lung cancer: a review. |
| Journal |
|
| Reference |
|
| Authors |
Weyhenmeyer B, Murphy AC, Prehn JH, Murphy BM |
| Title |
Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer. |
| Journal |
Exp Oncol 34:192-9 (2012) |
| LinkDB |
|